Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation

Complexities of TGF-β Targeted Cancer Therapy

(2012) Erin C. Connolly et al.   International Journal of Biological Sciences

Polymorphisms of TGFBR2 contribute to the progression of papillary thyroid carcinoma

(2012) Bong-Keun Choe et al.   Molecular & Cellular Toxicology

Genomic and epigenomic alterations in prostate cancer

(2012) Anna M. Aschelter et al.   Frontiers in Endocrinology

Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

(2011) L. Chen et al.   CLINICAL CANCER RESEARCH

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

(2011) Nicolas Mottet et al.   EUROPEAN UROLOGY

Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma

(2011) Wei Guo et al.   MOLECULAR BIOLOGY REPORTS

Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment

(2011) R. Aggarwal et al.   ONCOLOGIST

Apoptosis and the target genes of microRNA-21

(2011) Lindsey E. Becker Buscaglia et al.   Chinese Journal of Cancer

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

TGF-β receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-β

(2009) Andres Rojas et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Transforming growth factor beta (TGF-β) and inflammation in cancer

(2009) Brian Bierie et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility

(2009) A L Teixeira et al.   PHARMACOGENOMICS JOURNAL

Genetic Polymorphism in EGF Is Associated with Prostate Cancer Aggressiveness and Progression-Free Interval in Androgen Blockade-Treated Patients

(2008) A. L. Teixeira et al.   CLINICAL CANCER RESEARCH

Transforming Growth Factor-  Signaling-Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion

(2008) N. Cheng et al.   MOLECULAR CANCER RESEARCH